Key statistics
As of last trade, Terumo Corp (4543:TYO) traded at 2,466.50, 15.58% above the 52 week low of 2,134.00 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2,470.50 |
---|---|
High | 2,493.00 |
Low | 2,461.00 |
Bid | 2,466.00 |
Offer | 2,467.00 |
Previous close | 2,481.00 |
Average volume | 4.92m |
---|---|
Shares outstanding | 1.48bn |
Free float | 1.45bn |
P/E (TTM) | 31.41 |
Market cap | 3.67tn JPY |
EPS (TTM) | 78.98 JPY |
Annual div (ADY) | 26.00 JPY |
---|---|
Annual div yield (ADY) | 1.05% |
Div ex-date | Mar 28 2025 |
Div pay-date | Jun 25 2025 |
Data delayed at least 15 minutes, as of Jul 07 2025 05:05 BST.
More ▼
- Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter
- Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System
- Expanding a Stroke Legacy: Terumo Neuro Announces US Commercial Availability of the SOFIA™ 88 Neurovascular Support Catheter
- Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
- Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US
- Terumo Neuro Receives FDA Approval for Carotid Stent System
More ▼